Judge says J&J unit must pay nearly $4 million for misleading physicians about antipsychotic drug.
Bloomberg News (3/4, Fisk) reports that “Johnson & Johnson and its Janssen Pharmaceutica unit must pay West Virginia $3.95 million for misleading doctors about the risks and benefits of…Risperdal,” an atypical antipsychotic drug, “a judge ruled.” The state’s attorney general “sued Johnson & Johnson and its Janssen unit in 2004, claiming the companies violated the…